I am a seasoned executive leader with over 20 years of experience bridging the gap between business strategy and technical execution. My unique expertise spans business development, licensing, technology leadership, and product innovation across Life Sciences, MedTech, and digital health domains.
Throughout my career at Novartis, Merck, and Johnson & Johnson, I've demonstrated the ability to translate complex technical challenges into business opportunities, manage multi-million dollar programs, lead M&A due diligence, and build high-performing cross-functional teams. As a Founder/CTO of Denodia, I secured EU funding, scaled a platform to 5,000+ companies, and successfully negotiated B2B partnerships with global enterprises.
I excel at strategic leadership roles where business acumen meets technical depth—whether as an Executive Director driving organizational transformation, a BD&L leader identifying and closing strategic partnerships, or a CTO/VP Engineering building scalable technology organizations. My passion lies in creating value at the intersection of innovation, regulation, and market needs.
